Nu-Med Plus 

$0.02
6
+$0+0.57% Monday 13:30

Statistics

Day High
0.02
Day Low
0.02
52W High
0.06
52W Low
0.01
Volume
-
Avg. Volume
-
Mkt Cap
1.46M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

21NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
0
Expected EPS
0
Actual EPS
-0.0007

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-136,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NUMD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Masimo
MASI
Mkt Cap9.35B
Masimo Corporation specializes in noninvasive monitoring technologies, a direct competitor in the medical device space focusing on patient monitoring, similar to Nu-Med Plus' focus on nitric oxide delivery systems for patient care.
ICU Medical
ICUI
Mkt Cap2.97B
ICU Medical, Inc. provides infusion therapy, oncology, and critical care products, competing in the broader medical devices market for patient care, similar to Nu-Med Plus' therapeutic delivery systems.
Inogen
INGN
Mkt Cap190.45M
Inogen, Inc. offers portable oxygen concentrators, competing in the respiratory care market and directly with Nu-Med Plus' focus on enhancing patient respiratory conditions.
Penumbra
PEN
Mkt Cap12.8B
Penumbra, Inc. is a global healthcare company focused on innovative therapies, competing in the medical device sector with products that could overlap with Nu-Med Plus' market in therapeutic delivery systems.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation designs, manufactures, and markets medical devices used in various interventional medical specialties, potentially competing in the medical device market where Nu-Med Plus operates.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc is a global leader in medical technology, services, and solutions, with a broad portfolio that could compete with Nu-Med Plus in the medical devices and patient care market.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad array of healthcare products, including medical devices that could compete with Nu-Med Plus' offerings.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products that could compete in the broader medical device market relevant to Nu-Med Plus' focus areas.
Resmed
RMD
Mkt Cap29.87B
ResMed Inc. specializes in cloud-connectable medical devices for respiratory disorders, directly competing in the respiratory care market relevant to Nu-Med Plus' nitric oxide delivery systems.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation is one of the world's leading medical technology companies, offering products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that could indirectly compete with Nu-Med Plus.

About

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Mr. William Charles Hayde
Employees
2
Country
United States
ISIN
US67021R1041

Listings

0 Comments

Share your thoughts

FAQ

What is Nu-Med Plus stock price today?
The current price of NUMD is $0.02 USD — it has increased by +0.57% in the past 24 hours. Watch Nu-Med Plus stock price performance more closely on the chart.
What is Nu-Med Plus stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nu-Med Plus stocks are traded under the ticker NUMD.
Is Nu-Med Plus stock price growing?
NUMD stock has risen by +16.67% compared to the previous week, the month change is a +47.06% rise, over the last year Nu-Med Plus has showed a -65% decrease.
What is Nu-Med Plus market cap?
Today Nu-Med Plus has the market capitalization of 1.46M
What were Nu-Med Plus earnings last quarter?
NUMD earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nu-Med Plus revenue for the last year?
Nu-Med Plus revenue for the last year amounts to 0 USD.
What is Nu-Med Plus net income for the last year?
NUMD net income for the last year is -136,000 USD.
How many employees does Nu-Med Plus have?
As of May 06, 2026, the company has 2 employees.
In which sector is Nu-Med Plus located?
Nu-Med Plus operates in the Health & Wellness sector.
When did Nu-Med Plus complete a stock split?
Nu-Med Plus has not had any recent stock splits.
Where is Nu-Med Plus headquartered?
Nu-Med Plus is headquartered in Port Jefferson, United States.